norgestrel has been researched along with Adnexitis in 11 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 8 (72.73) | 18.7374 |
1990's | 3 (27.27) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Nordberg, OS; Segal, SJ | 1 |
Alvarez, F; Brache, V; Coutinho, E; Diaz, J; Diaz, MM; Diaz, S; el Mahgoub, S; Faundes, A; Pavez, M; Sivin, I | 1 |
Fayad, M; Kamel, M; Mooro, H; Osman, MI; Youssef, AF; Zahran, MM | 1 |
Allonen, H; Luukkainen, T; Toivonen, J | 1 |
Sivin, I | 1 |
Alvarez, F; Brache, V; Diaz, J; el Mahgoub, S; Faundes, A; Jimenez, E; McCarthy, T; Mishell, DR; Shoupe, D; Sivin, I | 1 |
Ratsula, K | 2 |
Coutinho, E; Diaz, J; Diaz, MM; Diaz, S; el Mahgoub, S; Faundes, A; Mattos, CE; Pavez, M; Sivin, I; Stern, J | 1 |
Digranes, A; Hofstad, T; Sandvei, R; Steier, AJ; Ulstein, M | 1 |
5 trial(s) available for norgestrel and Adnexitis
Article | Year |
---|---|
Intrauterine contraception with copper and with levonorgestrel: a randomized study of the TCu 380Ag and levonorgestrel 20 mcg/day devices.
Topics: Adolescent; Adult; Clinical Trials as Topic; Contraceptives, Oral, Combined; Female; Humans; Intrauterine Device Expulsion; Intrauterine Devices, Copper; Levonorgestrel; Menstrual Cycle; Norgestrel; Pelvic Inflammatory Disease; Pregnancy | 1984 |
Protective effect of intrauterine release of levonorgestrel on pelvic infection: three years' comparative experience of levonorgestrel- and copper-releasing intrauterine devices.
Topics: Adult; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Life Tables; Norgestrel; Pelvic Inflammatory Disease; Random Allocation | 1991 |
Long-term contraception with the levonorgestrel 20 mcg/day (LNg 20) and the copper T 380Ag intrauterine devices: a five-year randomized study.
Topics: Adolescent; Adult; Amenorrhea; Copper; Drug Implants; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Longitudinal Studies; Norgestrel; Patient Dropouts; Pelvic Inflammatory Disease | 1990 |
Two years of intrauterine contraception with levonorgestrel and with copper: a randomized comparison of the TCu 380Ag and levonorgestrel 20 mcg/day devices.
Topics: Adolescent; Adult; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Norgestrel; Pain; Pelvic Inflammatory Disease; Pregnancy; Random Allocation | 1987 |
Microflora of cervical and vaginal secretion in women using copper- and norgestrel-releasing IUCDs.
Topics: Adolescent; Adult; Cervix Uteri; Female; Humans; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Norgestrel; Pelvic Inflammatory Disease; Prospective Studies; Random Allocation; Risk Factors; Vagina | 1987 |
6 other study(ies) available for norgestrel and Adnexitis
Article | Year |
---|---|
Sixth fertility and sterility congress--a review.
Topics: Biology; Chlormadinone Acetate; Clomiphene; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Copper; Disease; Embolism; Endocrine System; Estrogens; Evaluation Studies as Topic; Family Planning Services; Hormones; Incidence; Infections; Injections; Intrauterine Devices; Medroxyprogesterone Acetate; Menstruation Disturbances; Norgestrel; Pelvic Inflammatory Disease; Physiology; Progesterone Congeners; Quinestrol; Research; Research Design; Therapeutics; Thromboembolism; Time; Uterine Perforation; Vascular Diseases; Zinc | 1968 |
Fertility regulation technology: status and prospects.
Topics: Abortifacient Agents; Abortion, Induced; Biology; Blood; Blood Coagulation; Chorionic Gonadotropin; Coitus Interruptus; Condoms; Contraception; Contraception, Immunologic; Contraceptive Agents; Contraceptive Agents, Female; Contraceptive Agents, Male; Contraceptive Devices, Female; Contraceptives, Oral; Contraceptives, Oral, Hormonal; Contraceptives, Postcoital; Corpus Luteum; Culdoscopy; Curettage; Diagnosis; Diethylstilbestrol; Disease; Economics; Electrocoagulation; Endocrine System; Endoscopy; Estrogens; Family Planning Services; Fertilization; General Surgery; Genitalia; Genitalia, Female; Germ Cells; Gonadotropins; Gonadotropins, Pituitary; Hormones; Infections; Intrauterine Devices; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Laparoscopy; Laparotomy; Luteinizing Hormone; Membrane Proteins; Menstruation; Menstruation Disturbances; Natural Family Planning Methods; Norgestrel; Obstetric Surgical Procedures; Ovary; Ovum; Pelvic Inflammatory Disease; Physical Examination; Physiology; Pituitary Hormone-Releasing Hormones; Prostaglandins; Reproduction; Research; Spermatocidal Agents; Spermatozoa; Sterilization, Reproductive; Sterilization, Tubal; Technology; Therapeutics; Urogenital System; Vacuum Curettage; Vasectomy | 1977 |
Effects of contraceptive pills and intrauterine devices on urinary bladder.
Topics: Adult; Bacteriuria; Contraceptives, Oral; Contraceptives, Oral, Synthetic; Escherichia coli Infections; Ethinyl Estradiol; Female; Humans; Intrauterine Devices; Lynestrenol; Mestranol; Norethindrone; Norgestrel; Pelvic Inflammatory Disease; Staphylococcal Infections; Streptococcal Infections; Urinary Bladder Diseases | 1976 |
Protective effect of intrauterine release of levonorgestrel on pelvic infection: three years' comparative experience of levonorgestrel- and copper-releasing intrauterine devices.
Topics: Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Copper; Levonorgestrel; Norgestrel; Pelvic Inflammatory Disease | 1991 |
Clinical performance of a levonorgestrel-releasing intracervical contraceptive device during the first two years of use.
Topics: Female; Humans; Intrauterine Device Expulsion; Intrauterine Devices, Medicated; Levonorgestrel; Norgestrel; Patient Compliance; Pelvic Inflammatory Disease; Pregnancy | 1989 |
Clinical performance of a levonorgestrel-releasing intracervical contraceptive device during the first year of use.
Topics: Adult; Carbamazepine; Cervix Uteri; Contraceptive Devices, Female; Female; Humans; Levonorgestrel; Norgestrel; Pelvic Inflammatory Disease; Pregnancy | 1987 |